medicoKIT GmbH

At medicoKIT GmbH researchers are evaluating new strategies to reduce heart‑related risk, focusing on innovative therapies and outcome measures in patients with established vascular conditions.

• Atherosclerosis Cardiovascular Disease
• Orforglipron cardiovascular outcomes study
• Reduction of major CV events

The site’s commercial laboratory setting enables precise biomarker analysis to support cardiovascular research in Goch, Germany.

Clinical work at the centre includes trials aimed at improving gut health, with a particular emphasis on functional bowel disorders and chronic constipation.

• Diarrhoea‑dominant irritable bowel syndrome
• Mixed‑type irritable bowel syndrome
• Dyspeptic digestive complaints (cramps, flatulence, bloating)
• Chronic constipation

Advanced microbiome and herbal‑based interventions are tested using the facility’s analytical capabilities.

The laboratory conducts vaccine‑focused studies to assess the humoral immune response and long‑term safety of novel immunizations for viral illnesses.

• Respiratory syncytial virus (RSV) vaccine immunogenicity
• Human Metapneumovirus (hMPV) vaccine evaluation
• Herpes Zoster vaccine efficacy and safety

These trials contribute to broader public‑health efforts by generating data on protective immunity in older adults.

Researchers are investigating novel analgesic approaches for patients suffering from persistent low back pain when conventional non‑opioid options have failed.

• Chronic non‑specific low back pain

The study design emphasizes pain‑reduction outcomes and tolerability in a real‑world patient population.

Trials at the site address metabolic health, including kidney function and broader nutritional concerns linked to chronic disease.

• Chronic Kidney Disease
• Metabolic disorder management

Laboratory assays support precise evaluation of metabolic biomarkers throughout the studies.

The centre evaluates symptomatic treatments for upper‑airway infections, with a focus on rapid relief of throat discomfort.

• Acute pharyngitis

Lozenges containing benzydamine hydrochloride and dichlorobenzyl alcohol are compared against active and placebo controls.

Studies target common respiratory conditions, assessing both antimicrobial efficacy and vaccine‑induced protection.

• Acute bronchitis
• Respiratory Syncytial Virus infections
• RSV and hMPV lower respiratory tract disease prevention

Outcomes include symptom scores, viral load reduction, and safety monitoring in adult participants.

The facility conducts investigations on a range of viral pathogens, seeking to improve prophylactic and therapeutic options.

• Respiratory syncytial virus (RSV)
• Human Metapneumovirus (hMPV)
• Herpes Zoster

Immunogenicity, durability of response, and safety are key endpoints across these viral studies.

A dedicated trial explores the potential of a botanical compound to alleviate symptoms of major depressive disorder in mildly to moderately affected adults.

• Mild to moderate major depressive disorder

The study measures changes in depression rating scales and rates of clinical remission.